


























































What are the best routes to market for Remote Patient Monitoring (RPM) companies? A survey from 2020 suggested that 55 to 58% of European physicians believe that Remote Patient Monitoring (RPM) will play a key role in the future of care. But adoption continues to be a challenge and RPM companies need to figure out what is the most sustainable and scalable route to market. Join us in this roundtable with other senior leaders where we will discuss:
What are the most scalable and sustainable commercialization models for RPM (e.g. partnerships with payers, employers, hospitals, D2C, etc)?
Keys to success? Factors that determine the best route to market (e.g. geographies, disease, objective of the program -prevention, diagnosis, management, etc, others)
Implications of choosing one route to market vs. others (evidence requirements, pricing strategies, organization structure of the company, etc)
Is there an opportunity for RPM solutions to consider an ecosystem approach or a platform play for better adoption with RPM solutions?
EHR integration has not helped with RPM adoption so far. What is stopping adoption and how do we solve this? Should solutions consider vertical or horizontal integration for remote patient monitoring?